메뉴 건너뛰기




Volumn 44, Issue 11, 2008, Pages 1572-1576

Single nucleotide polymorphisms and haplotypes in the gene for vascular endothelial growth factor and risk of prostate cancer

Author keywords

Genetics; Haplotypes; Prostate cancer; Single nucleotide polymorphisms; VEGF; VEGF plasma levels

Indexed keywords

VASCULOTROPIN;

EID: 46049103944     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.04.021     Document Type: Article
Times cited : (34)

References (30)
  • 1
    • 0034076189 scopus 로고    scopus 로고
    • Mechanisms of angiogenesis and arteriogenesis
    • Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nature Med 6 (2000) 389-395
    • (2000) Nature Med , vol.6 , pp. 389-395
    • Carmeliet, P.1
  • 2
    • 0024801035 scopus 로고
    • Vascular permeability factor, an endothelial cell mitogen related to PDGF
    • Keck P.J., Hauser S.D., Krivi G., et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246 (1989) 1309-1312
    • (1989) Science , vol.246 , pp. 1309-1312
    • Keck, P.J.1    Hauser, S.D.2    Krivi, G.3
  • 3
    • 34247174730 scopus 로고    scopus 로고
    • The expression of vascular endothelial growth factor is associated with the risk of cancer progression after radical prostatectomy
    • Peyromaure M., Camparo P., Badoual C., Descazeaud A., and Dinh-Xuan A.T. The expression of vascular endothelial growth factor is associated with the risk of cancer progression after radical prostatectomy. BJU Int 99 (2007) 1150-1153
    • (2007) BJU Int , vol.99 , pp. 1150-1153
    • Peyromaure, M.1    Camparo, P.2    Badoual, C.3    Descazeaud, A.4    Dinh-Xuan, A.T.5
  • 4
    • 33845606748 scopus 로고    scopus 로고
    • Expression of vascular endothelial growth factor (VEGF) in locally invasive prostate cancer is prognostic for radiotherapy outcome
    • Green M.M., Hiley C.T., Shanks J.H., et al. Expression of vascular endothelial growth factor (VEGF) in locally invasive prostate cancer is prognostic for radiotherapy outcome. Int J Radiat Oncol Biol Phys 67 (2007) 84-90
    • (2007) Int J Radiat Oncol Biol Phys , vol.67 , pp. 84-90
    • Green, M.M.1    Hiley, C.T.2    Shanks, J.H.3
  • 5
    • 0035884219 scopus 로고    scopus 로고
    • Clinical trials of antiangiogenic drugs: opportunities, problems, and assessment of initial results
    • Kerbel R.S. Clinical trials of antiangiogenic drugs: opportunities, problems, and assessment of initial results. J Clin Oncol 19 (2001) 25
    • (2001) J Clin Oncol , vol.19 , pp. 25
    • Kerbel, R.S.1
  • 6
    • 2542421792 scopus 로고    scopus 로고
    • A randomized phase II trial of the antiangiogenic agent SU5416 in hormone-refractory prostate cancer
    • Stadler W.M., Cao D., Vogelzang N.J., et al. A randomized phase II trial of the antiangiogenic agent SU5416 in hormone-refractory prostate cancer. Clin Cancer Res 10 (2004) 3365-3370
    • (2004) Clin Cancer Res , vol.10 , pp. 3365-3370
    • Stadler, W.M.1    Cao, D.2    Vogelzang, N.J.3
  • 7
    • 0037096738 scopus 로고    scopus 로고
    • Influence of cytokine gene polymorphisms on the development of prostate cancer
    • McCarron S.L., Edwards S., Evans P.R., et al. Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res 62 (2002) 3369-3372
    • (2002) Cancer Res , vol.62 , pp. 3369-3372
    • McCarron, S.L.1    Edwards, S.2    Evans, P.R.3
  • 8
    • 0041621886 scopus 로고    scopus 로고
    • Vascular endothelial growth factor gene-460 C/T polymorphism is a biomarker for prostate cancer
    • Lin C.C., Wu H.C., Tsai F.J., Chen H.Y., and Chen W.C. Vascular endothelial growth factor gene-460 C/T polymorphism is a biomarker for prostate cancer. Urology 62 (2003) 374-377
    • (2003) Urology , vol.62 , pp. 374-377
    • Lin, C.C.1    Wu, H.C.2    Tsai, F.J.3    Chen, H.Y.4    Chen, W.C.5
  • 9
    • 33749267776 scopus 로고    scopus 로고
    • Association of VEGF genetic polymorphisms with prostate carcinoma risk and clinical outcome
    • Sfar S., Hassen E., Saad H., Mosbah F., and Chouchane L. Association of VEGF genetic polymorphisms with prostate carcinoma risk and clinical outcome. Cytokine 35 (2006) 21-28
    • (2006) Cytokine , vol.35 , pp. 21-28
    • Sfar, S.1    Hassen, E.2    Saad, H.3    Mosbah, F.4    Chouchane, L.5
  • 10
    • 38349183079 scopus 로고    scopus 로고
    • No association between polymorphism in the vascular endothelial growth factor gene at position-460 and sporadic prostate cancer in the Turkish population
    • Onen I.H., Konac E., Eroglu M., Guneri C., Biri H., and Ekmekci A. No association between polymorphism in the vascular endothelial growth factor gene at position-460 and sporadic prostate cancer in the Turkish population. Mol Biol Rep 35 (2008) 17-22
    • (2008) Mol Biol Rep , vol.35 , pp. 17-22
    • Onen, I.H.1    Konac, E.2    Eroglu, M.3    Guneri, C.4    Biri, H.5    Ekmekci, A.6
  • 11
    • 38449109288 scopus 로고    scopus 로고
    • Clinical implication of vascular endothelial growth factor T-460C polymorphism in the risk and progression of prostate cancer
    • Fukuda H., Tsuchiya N., Narita S., et al. Clinical implication of vascular endothelial growth factor T-460C polymorphism in the risk and progression of prostate cancer. Oncol Rep 18 (2007) 1155-1163
    • (2007) Oncol Rep , vol.18 , pp. 1155-1163
    • Fukuda, H.1    Tsuchiya, N.2    Narita, S.3
  • 12
    • 39449093139 scopus 로고    scopus 로고
    • The Glu228Ala polymorphism in the ligand binding domain of death receptor 4 is associated with increased risk for prostate cancer metastases
    • Langsenlehner T., Langsenlehner U., Renner W., et al. The Glu228Ala polymorphism in the ligand binding domain of death receptor 4 is associated with increased risk for prostate cancer metastases. Prostate 68 (2008) 264-268
    • (2008) Prostate , vol.68 , pp. 264-268
    • Langsenlehner, T.1    Langsenlehner, U.2    Renner, W.3
  • 13
    • 33846581376 scopus 로고    scopus 로고
    • Interleukin-10 [ATA] promoter haplotype and prostate cancer risk: a population-based study
    • Eder T., Mayer R., Langsenlehner U., et al. Interleukin-10 [ATA] promoter haplotype and prostate cancer risk: a population-based study. Eur J Cancer 43 (2007) 472-475
    • (2007) Eur J Cancer , vol.43 , pp. 472-475
    • Eder, T.1    Mayer, R.2    Langsenlehner, U.3
  • 14
    • 0036316846 scopus 로고    scopus 로고
    • A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes
    • Awata T., Inoue K., Kurihara S., et al. A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 51 (2002) 1635-1639
    • (2002) Diabetes , vol.51 , pp. 1635-1639
    • Awata, T.1    Inoue, K.2    Kurihara, S.3
  • 15
    • 0034509524 scopus 로고    scopus 로고
    • A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels
    • Renner W., Kotschan S., Hoffmann C., Obermayer-Pietsch B., and Pilger E. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 37 (2000) 443-448
    • (2000) J Vasc Res , vol.37 , pp. 443-448
    • Renner, W.1    Kotschan, S.2    Hoffmann, C.3    Obermayer-Pietsch, B.4    Pilger, E.5
  • 16
    • 0033400238 scopus 로고    scopus 로고
    • Novel polymorphisms in the promoter and 5′ UTR regions of the human vascular endothelial growth factor gene
    • Brogan I.J., Khan N., Isaac K., Hutchinson J.A., Pravica V., and Hutchinson I.V. Novel polymorphisms in the promoter and 5′ UTR regions of the human vascular endothelial growth factor gene. Hum Immunol 60 (1999) 1245-1249
    • (1999) Hum Immunol , vol.60 , pp. 1245-1249
    • Brogan, I.J.1    Khan, N.2    Isaac, K.3    Hutchinson, J.A.4    Pravica, V.5    Hutchinson, I.V.6
  • 17
    • 0033865580 scopus 로고    scopus 로고
    • Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production
    • Watson C.J., Webb N.J., Bottomley M.J., and Brenchley P.E. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 12 (2000) 1232-1235
    • (2000) Cytokine , vol.12 , pp. 1232-1235
    • Watson, C.J.1    Webb, N.J.2    Bottomley, M.J.3    Brenchley, P.E.4
  • 18
    • 0035071957 scopus 로고    scopus 로고
    • A new statistical method for haplotype reconstruction from population data
    • Stephens M., Smith N.J., and Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68 (2001) 978-989
    • (2001) Am J Hum Genet , vol.68 , pp. 978-989
    • Stephens, M.1    Smith, N.J.2    Donnelly, P.3
  • 20
    • 0036065699 scopus 로고    scopus 로고
    • SNP judgments and freedom of association
    • Hegele R.A. SNP judgments and freedom of association. Arterioscler Thromb Vasc Biol 22 (2002) 1058-1061
    • (2002) Arterioscler Thromb Vasc Biol , vol.22 , pp. 1058-1061
    • Hegele, R.A.1
  • 21
    • 33746808629 scopus 로고    scopus 로고
    • Role of vascular endothelial growth factor in prostate cancer
    • Delongchamps N.B., Peyromaure M., and Dinh-Xuan A.T. Role of vascular endothelial growth factor in prostate cancer. Urology 68 (2006) 244-248
    • (2006) Urology , vol.68 , pp. 244-248
    • Delongchamps, N.B.1    Peyromaure, M.2    Dinh-Xuan, A.T.3
  • 23
    • 33748458449 scopus 로고    scopus 로고
    • The role of vascular endothelial growth factor (VEGF) in inflammatory bowel disease
    • Ferrante M., Pierik M., Henckaerts L., et al. The role of vascular endothelial growth factor (VEGF) in inflammatory bowel disease. Inflamm Bowel Dis 12 (2006) 870-878
    • (2006) Inflamm Bowel Dis , vol.12 , pp. 870-878
    • Ferrante, M.1    Pierik, M.2    Henckaerts, L.3
  • 24
    • 50649087219 scopus 로고    scopus 로고
    • Nam RK, Zhang WW, Loblaw DA, et al. A genome-wide association screen identifies regions on chromosomes 1q25 and 7p21 as risk loci for sporadic prostate cancer. Prostate Cancer Prostatic Dis 2007. doi:10.1038/sj.pcan.4501010.
    • Nam RK, Zhang WW, Loblaw DA, et al. A genome-wide association screen identifies regions on chromosomes 1q25 and 7p21 as risk loci for sporadic prostate cancer. Prostate Cancer Prostatic Dis 2007. doi:10.1038/sj.pcan.4501010.
  • 25
    • 35748974205 scopus 로고    scopus 로고
    • A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study
    • Murabito J.M., Rosenberg C.L., Finger D., et al. A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study. BMC Med Genet 8 (2007) S6
    • (2007) BMC Med Genet , vol.8
    • Murabito, J.M.1    Rosenberg, C.L.2    Finger, D.3
  • 26
    • 38449103390 scopus 로고    scopus 로고
    • Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP
    • Duggan D., Zheng S.L., Knowlton M., et al. Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. J Natl Cancer Inst 99 (2007) 1836-1844
    • (2007) J Natl Cancer Inst , vol.99 , pp. 1836-1844
    • Duggan, D.1    Zheng, S.L.2    Knowlton, M.3
  • 27
    • 33745169697 scopus 로고    scopus 로고
    • A common variant associated with prostate cancer in European and African populations
    • Amundadottir L.T., Sulem P., Gudmundsson J., et al. A common variant associated with prostate cancer in European and African populations. Nat Genet 38 (2006) 652-658
    • (2006) Nat Genet , vol.38 , pp. 652-658
    • Amundadottir, L.T.1    Sulem, P.2    Gudmundsson, J.3
  • 28
    • 38749105099 scopus 로고    scopus 로고
    • Altered expression of genes regulating angiogenesis in experimental androgen-independent prostate cancer
    • Gustavsson H., Jennbacken K., Welén K., and Damber J.E. Altered expression of genes regulating angiogenesis in experimental androgen-independent prostate cancer. Prostate 68 (2008) 161-170
    • (2008) Prostate , vol.68 , pp. 161-170
    • Gustavsson, H.1    Jennbacken, K.2    Welén, K.3    Damber, J.E.4
  • 29
    • 34548770084 scopus 로고    scopus 로고
    • Hypoxia-inducible factor-1alpha (HIF-1alpha) gene polymorphisms, circulating insulin-like growth factor binding protein (IGFBP)-3 levels and prostate cancer
    • Li H., Bubley G.J., Balk S.P., et al. Hypoxia-inducible factor-1alpha (HIF-1alpha) gene polymorphisms, circulating insulin-like growth factor binding protein (IGFBP)-3 levels and prostate cancer. Prostate 67 (2007) 1354-1361
    • (2007) Prostate , vol.67 , pp. 1354-1361
    • Li, H.1    Bubley, G.J.2    Balk, S.P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.